search icon

    Market Snapshot

    • S&P Futures

      3,814.5

    • Dow Futures

      30,961

    • Nasdaq Futures

      11,557.75

    blog search icon

    Rain Therapeutics Inc.

    (NASDAQ:RAIN)

    $5.38

    $-0.18

    -3.24%

    Rain Therapeutics Inc. Chart

    RAIN Stock Price Today

    Rain Therapeutics Inc. (RAIN) stock declined over -3.24% intraday to trade at $5.38 a share on NASDAQ. The stock opened with a gain of 11.39% at $5.69 and touched an intraday high of $6.2, falling -3.24% against the last close of $5.56. The stock went to a low of $4.36 during the session.

    Stock Snapshot

    $5.56

    Prev. Close

    147.52 Million

    Market Cap

    $4.36

    Day Low

    $5.69

    Open

    26.51 Million

    Number of Shares

    $6.2

    Day High

    -

    P/E ratio

    -2.42

    EPS (TTM)

    5.29

    Cash Flow per Share

    5.71

    Free Float in %

    5.57

    Book Value

    613,940

    Volume

    Rain Therapeutics Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-01$5.69$6.2$4.36$5.38613,900
    2022-06-30$4.83$6$4.56$5.56341,400
    2022-06-29$4.12$4.99$4.007$4.94226,600
    2022-06-28$3.89$4.37$3.75$4.2289,400
    2022-06-27$3.72$3.99$3.455$3.93241,800
    2022-06-24$3.43$3.74$3.23$3.741,875,700
    2022-06-23$2.89$4.39$2.81$3.444,611,000
    2022-06-22$2.324$2.76$2.324$2.5964,500
    2022-06-21$2.412$2.45$2.32$2.3673,800
    2022-06-17$2.25$2.45$2.2$2.3278,000

    Contact Details

    8000 Jarvis Avenue
    Suite 204
    Newark, CA 94560
    United States

    Webiste:RAIN

    510 953 5559

    Company Information

    Employees-

    Beta-

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryPharmaceuticals

    About Company

    Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinical trial for intimal sarcoma, as well as RAD52 which is in preclinical trials for tumors, including breast, ovarian, pancreatic, prostate, and other cancers. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California.

    Frequently Asked Questions

    icon

    What is the current Rain Therapeutics Inc. (RAIN) stock price?

    Rain Therapeutics Inc. (NASDAQ: RAIN) stock price is $5.38 as of the last check on Friday, July 1. During the trading session, RAIN stock reached the peak price of $6.2 while $4.36 was the lowest point it dropped to.

    icon

    RAIN's industry and sector of operation?

    The NASDAQ listed RAIN is part of Pharmaceuticals industry that operates in the broader Health Care sector. Rain Therapeutics Inc. , a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States.

    icon

    Who are the executives of RAIN?

    Dr. Robert C. Doebele M.D., Ph.D.
    Co-Founder, Chairman of Scientific Advisory Board, Pres & Chief Scientific Officer
    Mr. Lucio Tozzi
    Sr. VP of Clinical Operations
    Kolbot By Ph.D.
    Sr. VP of Technical Operations
    Mr. Avanish Vellanki M.B.A.
    Co-Founder, CEO & Chairman

    icon

    What is the RAIN stock price today?

    RAIN stock traded closed the last session at $5.38, which is $-0.18 or -3.24% lower than its previous close of $5.56. RAIN's current trading price is 150.23% lower than its 52-week high of $22.22 where as its distance from 52-week low of 2.15% is -75.79%.

    icon

    How many employees does RAIN have?

    Number of RAIN employees currently stands at -. RAIN operates from 8000 Jarvis Avenue, Suite 204, Newark, CA 94560, United States.

    icon

    Link for RAIN official website?

    Official Webiste of $RAIN is: https://www.rainthera.com

    icon

    How do I contact RAIN?

    RAIN could be contacted at RAIN operates from 8000 Jarvis Avenue, Suite 204, Newark, CA 94560, United States, or at phone #510 953 5559 and can also be accessed through its website.

    icon

    How many shares of RAIN are traded daily?

    RAIN stock volume for the day was 613,940 shares while in the previous session number of RAIN shares traded was 613,900 . The average number of RAIN shares traded daily for last 3 months was 192.6 Thousands.

    icon

    How much did RAIN change today?

    The percentage change in RAIN stock occurred in the recent session was -3.24% while the dollar amount for the price change in RAIN stock was $-0.18.

    icon

    What price range RAIN stock been trading in?

    In the recent session, the day high for RAIN stock was $6.2 while the low for RAIN stock touched on the day was $4.36.

    icon

    What is the market cap of RAIN currently?

    The market value of RAIN currently stands at 147.52 Million with its latest stock price at $5.38 and 26.51 Million of its shares outstanding.